LaNua Medical

Company overview

LaNua Medical is an Irish medical device developer and University College Dublin spin-out founded in 2024. Led by CEO and co-founder Tom Fitzmaurice, it is developing ECORE for interventional radiologists treating vascular disorders and cancers through minimally invasive embolization.

ECORE uses an umbrella-shaped occlusive structure intended to block blood flow in a selected vessel segment while allowing guidewires and catheters to pass through it. The design aims to support controlled delivery of embolic agents or other therapies downstream and limit unwanted reflux into adjacent vessels. These are development objectives rather than established clinical benefits.

The company operates from the ATU iHub in Galway and raised €6 million in seed funding in December 2024. It also leads a separate €6 million DTIF-funded ECORE project with UCD and Integer Holdings, focused on development and clinical validation. That award funds the collaborative project and is separate from the company’s seed round.

^{[1][2][3][4][5]}

Products & regulatory status How does MedTechIndex get this information?

Summary

LaNua states that ECORE remains in development and is not cleared or approved for commercial distribution in any country or region. Its proposed uses across vascular disease and oncology are development applications, rather than authorized indications. ^[2][3]

The ECORE collaboration with UCD and Integer Holdings is intended to support device development and clinical validation. The company’s stated goals include controlled downstream delivery and reduced embolization reflux; these goals have not been presented here as proven patient outcomes. ^[2][3]

Regulatory snapshot How to read this snapshot

U.S. FDA

—

510(k) clearances

—

De Novo grants

—

PMA approvals

—

Recall events

Latest recorded source review: 2026-11-05.

Scope: selected product families.

Commercial portfolio snapshot

No commercially marketed product portfolio has been established in the reviewed material.

Commercial development

Endovascular embolization device

ECORE ↗

Development-stage device with an umbrella-shaped occlusive structure designed to block selected blood flow while allowing guidewires, catheters and targeted therapies to pass distally. It is intended to complement embolization procedures and limit unwanted reflux. ^[2]

In development · Not cleared or approved for commercial distribution